RecruitingNot applicableNCT07488754
Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)
Studying Embryonal tumor of neuroepithelial tissue
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical University of Warsaw
- Principal Investigator
- Przemysław Kunert, Professor MD PhDMedical University of Warsaw
- Intervention
- Radiation: Local, targeted therapy with alpha emitter [225Ac]Ac-DOTA-SP (TAT)(radiation)
- Enrollment
- 35 target
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2025 – 2028
Study locations (2)
- Department of Neurosurgery, Medical University of Warsaw, Banacha 1a, Warsaw, Poland, Poland
- Department of Neurosurgery, National Instiute of Oncology, W.K. Roentgena 5, Warsaw, Poland, Poland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07488754 on ClinicalTrials.govOther trials for Embryonal tumor of neuroepithelial tissue
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07025018Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 MutationsHutchmed
- RECRUITINGNANCT06719440Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target VolumeCliniques universitaires Saint-Luc- Université Catholique de Louvain
- RECRUITINGPHASE2NCT06558214OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd TrialUniversity of Florida
- RECRUITINGPHASE3NCT06496971A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme PatientsNaviFUS Corporation
- RECRUITINGPHASE2NCT07364786Effect of Salovum® on Pressure, Oxygen and Inflammation in GlioblastomaPeter Siesjö
- RECRUITINGEARLY PHASE1NCT06828341A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 ExpressionJIANG LONGWEI
- RECRUITINGPHASE2NCT05708352A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care TreatmentCedars-Sinai Medical Center
- RECRUITINGPHASE1NCT05030298Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma TrialMayo Clinic
See all trials for Embryonal tumor of neuroepithelial tissue →